Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 296 entries
View as:

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00856271 Org: User:
Start: 08/31/04 End: 04/30/05 Due: 04/30/06

A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)

Phase: N/A Priority: Normal
NCT ID: NCT06660654 Org: User:
Start: 01/06/25 End: 09/30/27 Due: 09/30/28

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT01260584 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

Phase: N/A Priority: Normal
NCT ID: NCT02134015 Org: User:
Start: 03/31/14 End: 11/11/16 Due: 11/11/17

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00403481 Org: User:
Start: 11/30/06 End: 12/31/07 Due: 12/31/08

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00504556 Org: User:
Start: 06/30/07 End: 06/30/08 Due: 06/30/09

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT07015697 Org: User:
Start: 06/30/25 End: 12/31/28 Due: 12/31/29

A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05769751 Org: User:
Start: 03/15/23 End: 07/25/23 Due: 07/25/24

Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00430508 Org: User:
Start: 02/28/07 End: 05/31/08 Due: 05/31/09

DX-8951f in Treating Patients With Biliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005938 Org: User:
Start: 03/31/00 End: 04/30/05 Due: 04/30/06

EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan

Phase: N/A Priority: Normal
NCT ID: NCT05458401 Org: User:
Start: 11/11/22 End: 12/01/23 Due: 12/01/24

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06203210 Org: User:
Start: 05/21/24 End: 02/22/29 Due: 02/22/30

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00430638 Org: User:
Start: 12/31/06 End: 10/31/07 Due: 10/31/08

Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

Phase: N/A Priority: Normal
NCT ID: NCT02943785 Org: User:
Start: 03/21/17 End: 02/28/21 Due: 02/28/22

DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)

Phase: N/A Priority: Normal
NCT ID: NCT04014075 Org: User:
Start: 11/26/19 End: 02/13/24 Due: 02/13/25

Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

Phase: N/A Priority: Normal
NCT ID: NCT02673866 Org: User:
Start: 02/29/16 End: 02/28/17 Due: 02/28/18

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT00003951 Org: User:
Start: 06/30/99 End: 04/30/05 Due: 04/30/06

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Phase: N/A Priority: Normal
NCT ID: NCT00986154 Org: User:
Start: 10/31/09 End: 04/30/13 Due: 04/30/14

Olmesartan Pediatric Pharmacokinetic (PK) Study

Phase: N/A Priority: Normal
NCT ID: NCT00151814 Org: User:
Start: 09/30/05 End: 02/29/08 Due: 02/28/09

Vascular Improvement With Olmesartan Medoxomil Study

Phase: N/A Priority: Normal
NCT ID: NCT00772499 Org: User:
Start: 11/30/02 End: 07/31/05 Due: 07/31/06

WelChol® With Metformin in Treating Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00147719 Org: User:
Start: 06/30/04 End: 07/31/06 Due: 07/31/07

Study of Rivoglitazone in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00484198 Org: User:
Start: 04/23/07 End: 02/12/09 Due: 02/12/10

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03260491 Org: User:
Start: 10/30/17 End: 12/31/26 Due: 12/31/27

A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04479436 Org: User:
Start: 09/14/20 End: 02/03/22 Due: 02/03/23

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06172478 Org: User:
Start: 02/26/24 End: 04/30/26 Due: 04/30/27